Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
56 Cards in this Set
- Front
- Back
Opthalmic Drugs Mechanism of Action Opthalmic diagnostic –
|
Fluorescein sodium (Fluress) – a yellow water-soluble dibasic acid xanthine dye; produces intense green fluorescent. color in alkaline (pH>5) solution
Corneal defects appear bright green and are easily seen (resulting from trauma, infection, or other causes) |
|
Artificial tears:
|
Relief of dry eyes, and eye irritation associated with deficient tear production
|
|
Flourescein sodium:
Contraindications |
Hypersensitivity to product component
DO NOT use with soft contact lenses (resulting to contact lenses discoloration) |
|
Route of Administration Flourescein sodium:
|
Topical strips
|
|
Artificial Tears:
|
Ophthalmic lubricant
|
|
Mechanism of Action for Otic drugs
Otic Analgesic: Antipyrine-Benzocaine (Auralgan) |
Antipyrine is an analgesic while benzocaine is a local anesthetic
Also has glycerin (vehicle with emollient, hygroscopic and humectant properties) |
|
Otic Antibiotic:
Neomycin and Polymixin B Hydrocortisone (Cortisporin) |
Hydrocortisone is a corticosteroid used for its antiallergic, antipruritic and anti-inflammatory effects
|
|
Otic Ear Wax Removal Agent:
Carbamide Peroxide (Debrox) |
Wax dissolvers emulsify and disperse excessive build up of cerumen
Debrox is an antibacterial agent that releases oxygen to help remove cerumen accumulation |
|
Auralgan:
|
Topical anesthetic for relief of pain from otitis media
|
|
Neomycin-Polymixin B:
|
Tx superficial bacterial infection of the external auditory canal
Used to treat infection of mastoidectomy and fenestration cavities (perforated tympanic membrane) |
|
Carbamide Peroxide:
|
Removal of excessive ear wax build up
|
|
Auralgan/Neomycin-Polymixin B/ Carbamide Peroxide:
CONTRAINDICATIONS |
Hypersensitivities to any of its components
|
|
Insulin:
ANTIDIABETIC DRUGS |
Pancreatic hormone classified as a hypoglycemic drug; lowers blood glucose levels
|
|
Insulin hormone can correct
|
Polyuria (excessive urination)
Polydipsia (excessive thirst) Facilitates the movement of potassium from the extracellular fluid into the cell |
|
Potassium (K+):
|
K+ is necessary for:
Nerve impulse transmission Contraction of muscles Tissue growth and repair Acid-base balance maintenance |
|
Indications:
Insulin |
+Diabetic Ketoacidosis
Life-threatening insulin deficiency (severe hyperglycemia) |
|
Indications:
Potassium |
+Replacement therapy for hypokalemia due to condition that increase potassium excretion or depletion:
ALKALOSIS |
|
Contraindications:
Insulin |
Episodes of hypoglycemia
Sensitive to any ingredient of the product |
|
Potassium
contraindications |
Severe renal impairment with oliguria
Hyperkalemia from any cause Taking potassium-sparing diuretics +Acute dehydration |
|
Patient Information
Insulin |
Do not change the type of insulin except medical supervision
+Monitor blood and urine glucose levels and keep daily results Use same type of syringe unit to avoid dosage errors +Strict diet, exercise program, hygiene, and avoid infection are essential When prescribed new medication, ask whether it will change the effectiveness of your insulin |
|
Patient Information:
Potassium |
May cause GI upset, take after meals or with food and with a full glass of water
|
|
Mechanisms of action:
Estrogens |
+Estradiol – most potent estrogen produced
Important in development and maintenance of the female reproductive system Stimulate contraction of fallopian tubes Promote ovum movement Modify properties of cervical mucous Restore endometrium after menstruation |
|
Indications:
Progestins |
Amenorrhea and dysmenorrhea
Endometriosis |
|
Indications:
Estrogens |
Contraceptives
Estrogen deficiency Atrophic vaginitis Female hypogonadism Abnormal uterine bleeding |
|
Contraindications:
Progestins |
Hypersensitivity
Breast cancer +Liver disorders Thromboembolic disease |
|
Patient information:
Estrogens |
Notify physician if:
Pain in the groin or calves Sharp chest pain or sudden shortness of breath Abnormal vaginal bleeding Missed menstrual period/suspected pregnancy Lumps in the breast Sudden severe headache, dizziness or fainting Vision or speech disturbance +Weakness or numbness in an arm or leg Severe abdominal pain Yellowing of the eyes or skin Severe depression |
|
Mechanisms of Action
contraceptives |
Levonorgestrel and Ethinyl Estradiol (Levlen, Nordette)
Combination of a progestin and an estrogen hormone |
|
Indications:
Contraception for prevention of pregnancy |
Emergency contraception for pregnancy prevention following unprotected intercourse or suspected contraceptive failure
|
|
Patient Information (Roach, pg 376)
contraceptives |
Take exactly as directed at intervals not exceeding 24 hours, preferably at the same time each day
Missing a pill info can cause spotting or light bleeding |
|
Isometheptine mucate, acetaminophen and di-chloral-phenazone (Midrin) (Schedule IV drug)
|
Isometheptine Mucate is an unsaturated aliphatic amine with symphatomimetic properties;
Constricts dilated cranial and cerebral arterioles, Reducing the stimuli that lead to vascular HA Acetaminophen - Analgesic/Antipyretic Raises pain threshold against all types of headaches Dichloralphenazone Mild sedative Reduce patients emotional to the pain of both vascular and tension headaches |
|
Contraindications:
antimigraine drugs |
Glaucoma
Severe cases of renal disease Hypertension Organic heart disease Hepatic disease MAO inhibitor therapy |
|
Comprehensive Drug Abuse Prevention and Control Act of 1970
|
Establishes 5 schedules, dependent upon a drugs:
Potential for abuse, Medical usefulness, Degree of dependence, if any |
|
Schedule I substances
|
Highest potential for abuse and no acceptable medical usefulness
Examples: Heroin Marijuana LSD Peyote |
|
Schedule II substances:
|
High potential for abuse accepted medical usefulness
Abuse leads to severe psychological and physical dependence Examples: Morphine (AMMAL) Pentobarbital Meperidine (Demerol – some AMMALS) Amphetamines Codeine |
|
Schedule III substances:
|
Have a lesser degree of abuse potential with accepted medical usefulness
Abuse leads to moderate dependence. Examples: Paregoric Tylenol No.3 (AMMAL) Most codeine preparations, except cough syrups |
|
Schedule IV substances:
|
Low abuse potential with accepted medical usefulness
Limited Dependence problems Examples: Diazepam (AMMAL INJ/TABS) Isometheptine mucate, Acetaminophen, and Dichloralphenazone (AMMAL) |
|
Schedule V substances
|
Lowest abuse potential, accepted medical usefulness
Very limited dependence. Example: Lomotil |
|
Bulk Stock safe
|
Bulk custodian shall hold the combination
|
|
Recording of combinations
|
Combination change envelope (SF 700) shall be used and placed in the custody of the CO or officer designated in writing
|
|
Changing of combinations
|
Accomplished upon:
Change of custody Any suspicion of compromise +Not less frequently than every 24 months |
|
Perpetual Inventory of Narcotics, Alcohol, and Controlled Drugs (NAVMED 6710/5)
|
Inventory pages for bulk and working stock narcotics
+Must be changed every 12 months;beginning of each CY +Accurate quality control data of bulk and working stock medicinals shall be annotated on each page. (MFR, Lot #, Exp Date, MFR Date, NSN) |
|
CSIB Inventories
|
Controlled Substances Inventory Board (CSIB) shall inventory at least quarterly or more often if transactions warrant
|
|
The board is composed of at least 3 members
Minimum of 3 members must be present to conduct the inventory |
Senior enlisted personnel (E7-E9) and Department of the Navy civilians (GS7 and above) may serve on the board at the CO’s discretion
|
|
Excluded from serving on the board are:
|
Commanding Officer
Executive Officer Supply Officer Bulk Stock custodian Working Stock custodian |
|
Supply Dept provides
|
the senior member a copy of all issue documents of all controlled substances
|
|
CONTROLLED DRUG PRESCRIPTIONS
|
All authorized prescribers must prescribe controlled substances either by:
Electronic-order-entry or DD 1289 or coded facsimile |
|
Authorized prescribers, are exempt from DEA registration if in scope of Controlled Substance Act;
|
These prescribers must include on all prescriptions:
The prescriber's branch of service or agency Social Security Number |
|
Prescription numbers for controlled substances:
|
Preceded by the letter "C" and numbered sequentially
CO (or designated rep) must countersign IDC written prescriptions for controlled substances |
|
Use DEA Form 106 to report theft, lost or stolen of controlled substances:
|
Send one copy to the nearest Naval Investigative Service (NIS) representative
|
|
Submit a DD 200 request to the CO
|
Identifying controlled substances to be destroyed
Reasons for destroying them: - deterioration - sub-potency - purity - identity compromised |
|
When request is CO approved, destruction must be:
|
Presence of at least one CSIB member
For a two-person integrity |
|
The DD 200 form used for requesting destruction must contain:
|
Complete nomenclature and qty to be destroyed
Method used to accomplish destruction Signatures of the witnessing officer(s) |
|
NAVMED 6710/5
|
+Records are kept on file for THREE years and destroyed at the beginning of a new calendar year.
A separate NAVMED 6710/5 shall be prepared for each controlled medicinals received Lot numbers will vary |
|
CONTROLLED DRUG INVENTORY REPORT
|
+Submit report to CO within 5 working days after inventory
Preparation includes: +Cover sheet is memorandum format IAW correspondence Manual From: + Senior Member, CSIB To: Commanding Officer Via: Executive Officer Subject is: CONTROLLED SUBSTANCES INVENTORY REPORT FOR MONTH OF OCT 2007 |
|
Body of the report must address:
CDIR |
Dates of last Bulk and Working Stock safe combination changes
Signature block contains all three members of the CSIB |
|
Appointment letter format:
Standard Naval Letter |
Prepared on command letterhead from the CO to the individual
+Signed by the Commanding Officer Dated (usually stamped) at the time signed Collateral Duties List Cover letter to list is signed by CO Appointment must be by name, not position; updated regularly |